Kathryn Bueker - 01 Jul 2026 Form 4 Insider Report for HUBSPOT INC (HUBS)

Reporting relationship: Chief Financial Officer
Issuer ticker: HUBS
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 16:21:41 UTC
Prior SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Melissa Peterson, attorney-in-fact

Key filing fact

Kathryn Bueker filed Form 4 for HUBSPOT INC (HUBS) on 02 Jul 2026.

Key facts

This page summarizes Kathryn Bueker's Form 4 filing for HUBSPOT INC (HUBS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jul 2026, 16:21.

Change

Previous filing in this sequence was filed on 08 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001741660 Primary reporting owner

Bueker Kathryn

Relationship: Chief Financial Officer
Address: C/O HUBSPOT, INC., 2 CANAL PARK, CAMBRIDGE
Signature: /s/ Melissa Peterson, attorney-in-fact
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HUBS transaction

Common Stock

Tax liability

Transaction value
Shares: -781
Change %: -1.4%
Price: $187.72^*
Shares after: 56,349
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares withheld by Issuer to cover taxes associated with settlement of restricted stock units.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .